Endopeptidase O promotes Streptococcus suis immune evasion by cleaving the host- defence peptide cathelicidins

References

• Dutkiewicz J, Sroka J, Zajac V, et al. Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part I - Epidemiology. Ann Agric Environ Med. 2017;24(4):1–19. doi: 10.26444/aaem/79813
   PubMed Web of Science ®Google Scholar
• Huong VT, Ha N, Huy NT, et al. Epidemiology, clinical manifestations, and outcomes of Streptococcus suis infection in humans. Emerg Infect Dis. 2014;20(7):1105–1114. doi: 10.3201/eid2007.131594
   PubMed Web of Science ®Google Scholar
• Goyette-Desjardins G, Auger JP, Xu J, et al. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect. 2014;3(6):e45. doi: 10.1038/emi.2014.45
   PubMed Web of Science ®Google Scholar
• Lun ZR, Wang QP, Chen XG, et al. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis. 2007;7(3):201–209. doi: 10.1016/S1473-3099(07)70001-4
   PubMed Web of Science ®Google Scholar
• van Samkar A, Brouwer MC, Schultsz C, et al. Streptococcus suis meningitis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9(10):e0004191. doi: 10.1371/journal.pntd.0004191
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Nguyen HN, Taylor W, et al. Streptococcus suis, an important cause of adult bacterial meningitis in northern Vietnam. PLoS One. 2009;4(6):e5973. doi: 10.1371/journal.pone.0005973
   PubMed Web of Science ®Google Scholar
• Tang J, Wang C, Feng Y, et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLOS Med. 2006;3(5):e151. doi: 10.1371/journal.pmed.0030151
   PubMed Web of Science ®Google Scholar
• Ye C, Zheng H, Zhang J, et al. Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J Infect Dis. 2009;199(1):97–107. doi: 10.1086/594370
   PubMed Web of Science ®Google Scholar
• Segura M. Streptococcus suis: an emerging human threat. J Infect Dis. 2009;199(1):4–6. doi: 10.1086/594371
   PubMed Web of Science ®Google Scholar
• Alford MA, Baquir B, Santana FL, et al. Cathelicidin host defense peptides and inflammatory signaling: striking a balance. Front Microbiol. 2020;11:1902. doi: 10.3389/fmicb.2020.01902
   PubMed Web of Science ®Google Scholar
• LaRock CN, Nizet V. Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens. Biochim Biophys Acta. 2015;1848(11 Pt B):3047–3054. doi: 10.1016/j.bbamem.2015.02.010
   PubMed Web of Science ®Google Scholar
• Hancock RE, Haney EF, Gill EE. The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol. 2016;16(5):321–334. doi: 10.1038/nri.2016.29
   PubMed Web of Science ®Google Scholar
• Pachon-Ibanez ME, Smani Y, Pachon J, et al. Perspectives for clinical use of engineered human host defense antimicrobial peptides. FEMS Microbiol Rev. 2017;41(3):323–342. doi: 10.1093/femsre/fux012
   PubMed Web of Science ®Google Scholar
• Mookherjee N, Anderson MA, Haagsman HP, et al. Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov. 2020;19(5):311–332. doi: 10.1038/s41573-019-0058-8
   PubMed Web of Science ®Google Scholar
• Hilchie AL, Wuerth K, Hancock RE. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol. 2013;9(12):761–768. doi: 10.1038/nchembio.1393
   PubMed Web of Science ®Google Scholar
• Scheenstra MR, van Harten RM, Veldhuizen EJA, et al. Cathelicidins modulate TLR-Activation and inflammation. Front Immunol. 2020;11:1137. doi: 10.3389/fimmu.2020.01137
   PubMed Web of Science ®Google Scholar
• Coorens M, Scheenstra MR, Veldhuizen EJ, et al. Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR modulation, chemokine induction and regulation of phagocytosis. Sci Rep. 2017;7(1):40874. doi: 10.1038/srep40874
   PubMedGoogle Scholar
• Kurosaka K, Chen Q, Yarovinsky F, et al. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol. 2005;174(10):6257–6265. doi: 10.4049/jimmunol.174.10.6257
   PubMed Web of Science ®Google Scholar
• Biswas D, Ambalavanan P, Ravins M, et al. LL-37-mediated activation of host receptors is critical for defense against group a streptococcal infection. Cell Rep. 2021;34(9):108766. doi: 10.1016/j.celrep.2021.108766
   PubMed Web of Science ®Google Scholar
• Segura M, Fittipaldi N, Calzas C, et al. Critical Streptococcus suis virulence factors: are they all really critical? Trends Microbiol. 2017;25(7):585–599. doi: 10.1016/j.tim.2017.02.005
   PubMed Web of Science ®Google Scholar
• Bleuze M, Gottschalk M, Segura M. Neutrophils in Streptococcus suis infection: from host defense to pathology. Microorganisms. 2021;9(11):2392. doi: 10.3390/microorganisms9112392
   PubMed Web of Science ®Google Scholar
• Zhang W, Lu CP. Immunoproteomics of extracellular proteins of Chinese virulent strains of Streptococcus suis type 2. Proteomics. 2007;7(24):4468–4476. doi: 10.1002/pmic.200700294
   PubMed Web of Science ®Google Scholar
• Liu F, Li J, Yan K, et al. Binding of fibronectin to SsPepO facilitates the development of Streptococcus suis meningitis. J Infect Dis. 2018;217(6):973–982. doi: 10.1093/infdis/jix523
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yan K, Sun C, et al. Binding of Plasminogen to Streptococcus suis Protein Endopeptidase O Facilitates Evasion of Innate Immunity in Streptococcus suis. Front Microbiol. 2021;12:694103. doi: 10.3389/fmicb.2021.694103
   PubMed Web of Science ®Google Scholar
• Petersen TN, Brunak S, von Heijne G, et al. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011;8(10):785–786. doi: 10.1038/nmeth.1701
   PubMed Web of Science ®Google Scholar
• Letunic I, Khedkar S, Bork P. SMART: recent updates, new developments and status in 2020. Nucleic Acids Res. 2021;49(D1):D458–D460. doi: 10.1093/nar/gkaa937
   PubMed Web of Science ®Google Scholar
• Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22(22):4673–4680. doi: 10.1093/nar/22.22.4673
   PubMed Web of Science ®Google Scholar
• Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42(Web Server issue):W320–W324. doi: 10.1093/nar/gku316
   PubMed Web of Science ®Google Scholar
• Bienert S, Waterhouse A, de Beer TA, et al. The SWISS-MODEL Repository-new features and functionality. Nucleic Acids Res. 2017;45(D1):D313–D319. doi: 10.1093/nar/gkw1132
   PubMed Web of Science ®Google Scholar
• Okwumabua O, O'Connor M, Shull E. A polymerase chain reaction (PCR) assay specific for Streptococcus suis based on the gene encoding the glutamate dehydrogenase. FEMS Microbiology Letters. 2003;218(1):79–84. doi: 10.1111/j.1574-6968.2003.tb11501.x
   PubMed Web of Science ®Google Scholar
• Trieu-Cuot P, Carlier C, Poyart-Salmeron C, et al. Shuttle vectors containing a multiple cloning site and a lacZ alpha gene for conjugal transfer of DNA from Escherichia coli to gram-positive bacteria. Gene. 1991;102(1):99–104. doi: 10.1016/0378-1119(91)90546-n
   PubMed Web of Science ®Google Scholar
• Takamatsu D, Osaki M, Sekizaki T. Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid. 2001;46(2):140–148. doi: 10.1006/plas.2001.1532
   PubMed Web of Science ®Google Scholar
• Takamatsu D, Osaki M, Sekizaki T. Construction and characterization of Streptococcus suis-Escherichia coli shuttle cloning vectors. Plasmid. 2001;45(2):101–113. doi: 10.1006/plas.2000.1510
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhong LL, Srinivas S, et al. Spread of MCR-3 Colistin resistance in China: an epidemiological, genomic and mechanistic study. EBioMedicine. 2018;34:139–157. doi: 10.1016/j.ebiom.2018.07.027
   PubMed Web of Science ®Google Scholar
• Donahoe SL, Phalen DN, McAllan BM, et al. Differential gamma interferon- and tumor necrosis factor alpha-driven cytokine response distinguishes acute infection of a metatherian host with Toxoplasma gondii and Neospora caninum. Infect Immun. 2017;85(6):e00173–17. doi: 10.1128/IAI.00173-17
   PubMed Web of Science ®Google Scholar
• Lei R, Hou J, Chen Q, et al. Self-assembling myristoylated human alpha-defensin 5 as a next-generation nanobiotics potentiates therapeutic efficacy in bacterial infection. ACS Nano. 2018;12(6):5284–5296. doi: 10.1021/acsnano.7b09109
   PubMed Web of Science ®Google Scholar
• van Harten RM, van Woudenbergh E, van Dijk A, et al. Cathelicidins: Immunomodulatory Antimicrobials. Vaccines (Basel). 2018;6(3):63. doi: 10.3390/vaccines6030063
   PubMed Web of Science ®Google Scholar
• Nagaoka I, Tamura H, Hirata M. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol. 2006;176(5):3044–3052. doi: 10.4049/jimmunol.176.5.3044
   PubMed Web of Science ®Google Scholar
• Tang X, Basavarajappa D, Haeggstrom JZ, et al. P2X7 receptor regulates internalization of antimicrobial peptide LL-37 by human macrophages that promotes intracellular pathogen clearance. J Immunol. 2015;195(3):1191–1201. doi: 10.4049/jimmunol.1402845
   PubMed Web of Science ®Google Scholar
• Duarte-Mata DI, Salinas-Carmona MC. Antimicrobial peptides immune modulation role in intracellular bacterial infection. Front Immunol. 2023;14:1119574. doi: 10.3389/fimmu.2023.1119574
   PubMed Web of Science ®Google Scholar
• Agarwal V, Sroka M, Fulde M, et al. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence. J Biol Chem. 2014;289(22):15833–15844. doi: 10.1074/jbc.M113.530212
   PubMed Web of Science ®Google Scholar
• Agarwal V, Kuchipudi A, Fulde M, et al. Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells. J Biol Chem. 2013;288(10):6849–6863. doi: 10.1074/jbc.M112.405530
   PubMed Web of Science ®Google Scholar
• Chen C, Liu H, Zabad S, et al. MoonProt 3.0: an update of the moonlighting proteins database. Nucleic Acids Res. 2021;49(D1):D368–D372. doi: 10.1093/nar/gkaa1101
   PubMed Web of Science ®Google Scholar
• Cole JN, Nizet V, Kudva IT, et al. Bacterial Evasion of Host Antimicrobial Peptide Defenses. Microbiol Spectr. 2016;4(1):10. doi: 10.1128/microbiolspec.VMBF-0006-2015
   Web of Science ®Google Scholar
• Xie F, Zan Y, Zhang Y, et al. The cysteine protease ApdS from Streptococcus suis promotes evasion of innate immune defenses by cleaving the antimicrobial peptide cathelicidin LL-37. J Biol Chem. 2019;294(47):17962–17977. doi: 10.1074/jbc.RA119.009441
   PubMed Web of Science ®Google Scholar
• Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 2010;38(Database issue):D227–D233. doi: 10.1093/nar/gkp971
   PubMedGoogle Scholar
• Schmidtchen A, Frick IM, Andersson E, et al. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol. 2002;46(1):157–168. doi: 10.1046/j.1365-2958.2002.03146.x
   PubMed Web of Science ®Google Scholar
• Sieprawska-Lupa M, Mydel P, Krawczyk K, et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother. 2004;48(12):4673–4679. doi: 10.1128/AAC.48.12.4673-4679.2004
   PubMed Web of Science ®Google Scholar
• Vandamme D, Landuyt B, Luyten W, et al. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012;280(1):22–35. doi: 10.1016/j.cellimm.2012.11.009
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159–175. doi: 10.1038/nri3399
   PubMed Web of Science ®Google Scholar
• Sigurdardottir T, Andersson P, Davoudi M, et al. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother. 2006;50(9):2983–2989. doi: 10.1128/AAC.01583-05
   PubMed Web of Science ®Google Scholar
• Bei Y, Pan LL, Zhou Q, et al. Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury. BMC Med. 2019;17(1):42. doi: 10.1186/s12916-019-1268-y
   PubMedGoogle Scholar